AngioDynamics, Inc. Payments to Acquire Marketable Securities
AngioDynamics, Inc. (ANGO) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2016-05-31, per its 10-K filed 2016-08-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2016-08-01
- AngioDynamics, Inc. payments to acquire marketable securities for the quarter ending 2015-05-31 was $0.00.
- AngioDynamics, Inc. payments to acquire marketable securities for the quarter ending 2014-05-31 was $0.00.
- AngioDynamics, Inc. payments to acquire marketable securities for the quarter ending 2014-02-28 was $0.00.
- AngioDynamics, Inc. payments to acquire marketable securities for the quarter ending 2013-05-31 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. payments to acquire marketable securities for fiscal 2016 was $0.00.
- AngioDynamics, Inc. payments to acquire marketable securities for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- AngioDynamics, Inc. payments to acquire marketable securities for fiscal 2014 was $25.00K, a 99.51% decline from fiscal 2013.
- AngioDynamics, Inc. payments to acquire marketable securities for fiscal 2013 was $5.13M, a 95.85% decline from fiscal 2012.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2016-05-31 | $0.00 10-K · filed 2016-08-01 | |||
| 2015-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $0.00 10-K · filed 2016-08-01 | ||
| 2015-02-28 | $0.00 10-Q · filed 2015-04-09 | |||
| 2014-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $0.00 derived: sum of 2 quarters · filed 2016-08-01 | $25.00K 10-K · filed 2016-08-01 | |
| 2014-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-09 | $25.00K 10-Q · filed 2015-04-09 | ||
| 2013-11-30 | $25.00K 10-Q · filed 2014-01-09 | |||
| 2013-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-10 | $0.00 derived: sum of 2 quarters · filed 2015-08-10 | $172.00K derived: sum of 3 quarters · filed 2015-08-10 | $5.13M 10-K · filed 2015-08-10 |
| 2013-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-09 | $172.00K derived: sum of 2 quarters · filed 2014-04-09 | $5.13M 10-Q · filed 2014-04-09 | $10.43M derived: sum of 4 quarters · filed 2015-01-12 |
| 2012-11-30 | $172.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-09 | $5.13M 10-Q · filed 2013-01-09 | $10.43M derived: sum of 3 quarters · filed 2015-01-12 | $51.10M derived: sum of 4 quarters · filed 2015-01-12 |
| 2012-08-31 | $4.96M 10-Q/A · filed 2012-11-09 | $10.25M derived: sum of 2 quarters · filed 2015-01-12 | $50.92M derived: sum of 3 quarters · filed 2015-01-12 | $86.27M derived: sum of 4 quarters · filed 2015-01-12 |
| 2012-05-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-12 | $45.96M derived: sum of 2 quarters · filed 2015-01-12 | $81.31M derived: sum of 3 quarters · filed 2015-01-12 | $123.61M 10-K · filed 2015-01-12 |
| 2012-02-29 | $40.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-09 | $76.02M derived: sum of 2 quarters · filed 2013-04-09 | $118.32M 10-Q · filed 2013-04-09 | $136.81M derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-11-30 | $35.35M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-09 | $77.65M 10-Q · filed 2013-01-09 | $96.14M derived: sum of 3 quarters · filed 2013-08-14 | $117.85M derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-08-31 | $42.30M 10-Q/A · filed 2012-11-09 | $60.79M derived: sum of 2 quarters · filed 2013-08-14 | $82.50M derived: sum of 3 quarters · filed 2013-08-14 | $202.71M derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-05-31 | $18.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $40.20M derived: sum of 2 quarters · filed 2013-08-14 | $160.41M derived: sum of 3 quarters · filed 2013-08-14 | $168.48M 10-K · filed 2013-08-14 |
| 2011-02-28 | $21.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-04-09 | $141.93M derived: sum of 2 quarters · filed 2012-04-09 | $149.99M 10-Q · filed 2012-04-09 | |
| 2010-11-30 | $120.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-05 | $128.27M 10-Q · filed 2012-01-05 | ||
| 2010-08-31 | $8.06M 10-Q · filed 2011-10-11 | |||
| 2010-05-31 | $42.44M 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |